Healthcare & Medical Devices Global On demand · 24-48h

Global Non-woven Healthcare Fabrics Market Strategic Research Report

Global Non-woven Healthcare Fabrics Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Non-woven Healthcare Fabrics Market
$3.08B2025
6.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PP Non-woven Healthcare Fabrics, PET Non-woven Healthcare Fabrics, Viscose Non-woven Healthcare Fabrics

By Application: Hospitals and Clinics, Home Healthcare, Personal Care Brands, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Kimberly-Clark Corporation, Berry Global Group Inc, Freudenberg Group, Ahlstrom-Munksjö, Cardinal Health, Molnlycke Health Care, Asahi Kasei Corporation, Avgol Ltd., PFNonwovens, Suominen Corporation, Hollingsworth & Vose Company, Toray Industries, Inc., Medline Industries, Intco Medical, Sunshine Non Woven Fabric Co., Ltd

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$3.08B
Billion USD
Forecast CAGR
6.1%
2025-2032
Forecast 2032
$4.7B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Non-woven Healthcare Fabrics market size is predicted to grow from US$ 3,081 million in 2025 to US$ 4,648 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

In 2025, global Non-woven Healthcare Fabrics production reached approximately 1.31 million tons, with an average global market price of around USD 2,400 per ton.

The gross profit margin of major companies in the industry is between 12.75%–25.48%.

In 2025, the global production capacity of Non-woven Healthcare Fabrics was approximately 1.73 million tons.

Non-woven Healthcare Fabrics are engineered fiber webs used in hygiene, medical care and personal health products. They are made through spunbond, meltblown, spunlace, needlepunch or composite processes and can provide softness, absorbency, filtration, barrier protection, breathability and skin comfort. The product is used in wipes, masks, gowns, drapes, diapers, sanitary products, wound care, disposable bedding and health protection goods. The market excludes woven textiles, knitted fabrics, finished diapers or masks counted as final products, and non-healthcare industrial nonwoven materials.

The industry chain includes polypropylene, polyester, viscose, wood pulp, bicomponent fibers, absorbent additives, binders, antimicrobial agents, packaging materials and nonwoven production equipment. Midstream production involves fiber preparation, web forming, bonding, hydroentangling, meltblowing, finishing, slitting, winding and inspection. Downstream demand comes from medical disposables, hygiene products, personal care, elderly care, infection control, household cleaning and healthcare packaging. Growth is supported by aging populations, infection prevention, disposable medical consumption and rising hygiene standards.

Medical hygiene products, daily care and disposable health supplies consumption growth expand market of non-woven healthcare fabrics. Breathable, soft and antibacterial characteristics fit medical dressing and personal care scenarios. Environment-friendly spinning process optimizes skin-friendly performance of finished fabrics.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-woven Healthcare Fabrics market?

What factors are driving Non-woven Healthcare Fabrics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-woven Healthcare Fabrics market opportunities vary by end market size?

How does Non-woven Healthcare Fabrics break out by Type, by Application?

This report presents a comprehensive overview of the global Non-woven Healthcare Fabrics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PP Non-woven Healthcare Fabrics
  • PET Non-woven Healthcare Fabrics
  • Viscose Non-woven Healthcare Fabrics

Segment by Fabric Technology

  • Spunbond Non-woven Fabrics
  • Meltblown Non-woven Fabrics
  • Spunlace Non-woven Fabrics

Segment by Fabric Weight

  • Lightweight(≤30 g/m²)
  • Medium Weight(31–80 g/m²)
  • Heavyweight(>80 g/m²)

Segment by Application

  • Hospitals and Clinics
  • Home Healthcare
  • Personal Care Brands
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Non-woven Healthcare Fabrics market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals and Clinics, Home Healthcare, Personal Care Brands evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Non-woven Healthcare Fabrics Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.08B
2025
Forecast
$4.7B
2032
CAGR
6.1%
2025–2032
Regiões
5
global
Key companies
Kimberly-Clark CorporationBerry Global Group IncFreudenberg GroupAhlstrom-MunksjöCardinal HealthMolnlycke Health CareAsahi Kasei CorporationAvgol Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PP Non-woven Healthcare FabricsPET Non-woven Healthcare FabricsViscose Non-woven Healthcare Fabrics
By Application
Hospitals and ClinicsHome HealthcarePersonal Care BrandsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PP Non-woven Healthcare Fabrics
  • 3.1.3 PET Non-woven Healthcare Fabrics
  • 3.1.4 Viscose Non-woven Healthcare Fabrics
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals and Clinics
  • 4.1.3 Home Healthcare
  • 4.1.4 Personal Care Brands
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Kimberly-Clark Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Berry Global Group Inc
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Freudenberg Group
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ahlstrom-Munksjö
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cardinal Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Molnlycke Health Care
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Asahi Kasei Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Avgol Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 PFNonwovens
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Suominen Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hollingsworth & Vose Company
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Toray Industries, Inc.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Medline Industries
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Intco Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sunshine Non Woven Fabric Co., Ltd
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Non-woven Healthcare Fabrics market size?
The global Non-woven Healthcare Fabrics market is estimated at US$ 3.08 billion in 2025 (base year) and is projected to reach US$ 4.65 billion by 2032.
What growth rate is expected for the Non-woven Healthcare Fabrics market through 2032?
The market is expected to grow at a CAGR of 6.1% from 2026 to 2032, expanding from US$ 3.08 billion in 2025 to US$ 4.65 billion in 2032, roughly 1.5 times its base-year value.
How is Non-woven Healthcare Fabrics defined?
In 2025, global Non-woven Healthcare Fabrics production reached approximately 1.31 million tons, with an average global market price of around USD 2,400 per ton.
How is the Non-woven Healthcare Fabrics market segmented by type?
By type, the market is segmented into PP Non-woven Healthcare Fabrics, PET Non-woven Healthcare Fabrics and Viscose Non-woven Healthcare Fabrics.
What are the key applications of Non-woven Healthcare Fabrics?
Key applications covered include Hospitals and Clinics, Home Healthcare, Personal Care Brands and Other.
Which companies are profiled in the Non-woven Healthcare Fabrics market report?
Key players profiled include Kimberly-Clark Corporation, Berry Global Group Inc, Freudenberg Group, Ahlstrom-Munksjö, Cardinal Health, Molnlycke Health Care, Asahi Kasei Corporation and Avgol Ltd., among 15 companies covered in total.
What geographies does the Non-woven Healthcare Fabrics market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Non-woven Healthcare Fabrics?
Growth is supported by aging populations, infection prevention, disposable medical consumption and rising hygiene standards.
What are the main risks and barriers in the Non-woven Healthcare Fabrics market?
They are made through spunbond, meltblown, spunlace, needlepunch or composite processes and can provide softness, absorbency, filtration, barrier protection, breathability and skin comfort.
Who should buy the Non-woven Healthcare Fabrics market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals and Clinics, Home Healthcare and Personal Care Brands, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Non-woven Healthcare Fabrics market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.